Peijia Medical Limited (HKG:9996)
Hong Kong · Delayed Price · Currency is HKD 4.810
0.00 (0.00%)
Sep 30, 2026, 4:08 PM HKT
Peijia Medical Stock Forecast
Stock Price Forecast
According to 4 analysts polled by S&P Global, Peijia Medical stock has a consensus rating of "Strong Buy" and an average price target of $9.81. The average 1-year stock price forecast is 103.95% higher than the current stock price, while the lowest is $8.62 (+79.21%) and the highest is $10.71 (+122.66%).
Price Target: $9.81 (+103.95%)
Analyst Consensus: Strong Buy
Price Target
Chart* Price targets were last updated on Aug 28, 2026.
Analyst Ratings
The average analyst rating for Peijia Medical stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Mar '26 | Apr '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst CICC No rating | CICC | Buy Maintains $10.00 | Buy | Maintains | $10.00 | +107.90% | Aug 28, 2026 |
Unknown Analyst Huatai Securities No rating | Huatai Securities | Buy Maintains $10.69 | Buy | Maintains | $10.69 | +122.25% | Aug 26, 2026 |
Financial Forecast
Revenue This Year
919.87M
from 712.87M
Increased by 29.04%
Revenue Next Year
1.18B
from 919.87M
Increased by 27.86%
EPS This Year
0.01
from -0.31
EPS Next Year
0.14
from 0.01
Increased by 2,700.00%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.